The diabetic brain and cognition (Q40098573)

17 September 2017

title

The diabetic brain and cognition (English)

1 reference

17 September 2017

Zyta Beata Wojszel

24

0 references

Edna Grünblatt

Edna Grünblatt

8

0 references

Amos D. Korczyn

Amos D Korczyn

2

0 references

Mohammad Amjad Kamal

Mohammad Amjad Kamal

10

0 references

Sameh S. Ali

Sameh S Ali

3

0 references

Tali Cukierman-Yaffe

27

Tali Cukierman-Yaffe

1 reference

17 September 2017

6

Michael Chopp

1 reference

17 September 2017

23

László Vécsei

1 reference

17 September 2017

1

Peter Riederer

1 reference

17 September 2017

Melita Salkovic-Petrisic

19

Melita Salkovic-Petrisic

1 reference

17 September 2017

Ovidiu Bajenaru

4

1 reference

17 September 2017

Mun Seong Choi

5

1 reference

17 September 2017

Vesna Dermanovic-Dobrota

7

1 reference

17 September 2017

Kurt A Jellinger

9

1 reference

17 September 2017

Warda Kamal

11

1 reference

17 September 2017

Jerzy Leszek

12

1 reference

17 September 2017

Tanja Maria Sheldrick-Michel

13

1 reference

17 September 2017

Gohar Mushtaq

14

1 reference

17 September 2017

Bernard Meglic

15

1 reference

17 September 2017

Rachel Natovich

16

1 reference

17 September 2017

Zvezdan Pirtosek

17

1 reference

17 September 2017

Martin Rakusa

18

1 reference

17 September 2017

Reinhold Schmidt

20

1 reference

17 September 2017

Angelika Schmitt

21

1 reference

17 September 2017

G Ramachandra Sridhar

22

1 reference

17 September 2017

Hakan Yaman

25

1 reference

17 September 2017

Zheng G Zhang

26

1 reference

17 September 2017

publication date

1 August 2017

1 reference

Journal of Neural Transmission

17 September 2017

published in

1 reference

Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Insulin receptor signaling in rat hippocampus: A study in STZ (ICV) induced memory deficit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Beta-amyloid deposition in brains of subjects with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Molecular interaction of human brain acetylcholinesterase with a natural inhibitor huperzine-B: an enzoinformatics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

A nanotechnological approach to the management of Alzheimer disease and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Synaptic plasticity in the diabetic brain: advanced aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

The source of cerebral insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

The blood-brain barrier as a regulatory interface in the gut-brain axes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Insulin in the brain: There and back again

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Alzheimer's disease and type 2 diabetes: two diseases, one common link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Aberrant insulin signaling in Alzheimer's disease: current knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Brain MRI correlates of cognitive dysfunction in type 2 diabetes: the needle recovered from the haystack?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Cognition and diabetes: a lifespan perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Cerebral haemodynamics, cognition and brain volumes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Adult-born hippocampal neurons promote cognitive flexibility in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Alzheimer's disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Deregulation of brain insulin signaling in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Progress of Diabetic Severity and Risk of Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Experimental diabetes mellitus type 1 increases hippocampal content of kynurenic acid in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Novel aspect of ketone action: β-hydroxybutyrate increases brain synthesis of kynurenic acid in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Insulin and neurodegenerative disease: shared and specific mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

A Key Role of Insulin Receptors in Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

How does brain insulin resistance develop in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Brain metabolic dysfunction at the core of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Vascular risk factor detection and control may prevent Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Adult-born hippocampal dentate granule cells undergoing maturation modulate learning and memory in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Butyrylcholinesterase attenuates amyloid fibril formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Activation of sirtuin 1 attenuates cerebral ventricular streptozotocin-induced tau hyperphosphorylation and cognitive injuries in rat hippocampi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Modification of purinergic signaling in the hippocampus of streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Increased neural progenitors in vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Pioglitazone significantly prevented decreased rate of neural differentiation of mouse embryonic stem cells which was reduced by Pex11β knock-down.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Midlife and late-life obesity and the risk of dementia: cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Potential roles of insulin and IGF-1 in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Advanced glycation end products: sparking the development of diabetic vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Magnesium in Prevention and Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Obese men respond to cognitive but not to catabolic brain insulin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Risk of dementia in seniors with newly diagnosed diabetes: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Insulin promotes glycogen storage and cell proliferation in primary human astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

The Effect of Diabetes Medication on Cognitive Function: Evidence from the PATH Through Life Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Insulin increases glucose transfer across the blood-brain barrier in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Glucose metabolism and insulin receptor signal transduction in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Brain-wide pathway for waste clearance captured by contrast-enhanced MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

The effects of sitagliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Advances in the treatment of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Association of BDNF and BCHE with Alzheimer's disease: Meta-analysis based on 56 genetic case-control studies of 12,563 cases and 12,622 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Impairment of the glymphatic system after diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Hypoglycemia as a predictor of mortality in hospitalized elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Evidence of increased oxidative damage in subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Activity Dependency and Aging in the Regulation of Adult Neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Vascular cognitive impairment and Alzheimer's disease: role of cerebral hypoperfusion and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Central Insulin Action Activates Kupffer Cells by Suppressing Hepatic Vagal Activation via the Nicotinic Alpha 7 Acetylcholine Receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

21 January 2018

Diabetes in older adults

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Selective Insulin and Leptin Resistance in Metabolic Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

In vivo cross-sectional characterization of cerebral alterations induced by intracerebroventricular administration of streptozotocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Effects of erythropoietin on memory deficits and brain oxidative stress in the mouse models of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Association between comorbidities and dementia in diabetes mellitus patients: population-based retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Enhancement of β-amyloid oligomer accumulation after intracerebroventricular injection of streptozotocin, which involves central insulin signaling in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Diabetes, hyperglycaemia, and acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Effects of stress throughout the lifespan on the brain, behaviour and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Insulin Resistance and Future Cognitive Performance and Cognitive Decline in Elderly Patients with Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Early Cognitive Deficits in Type 2 Diabetes: A Population-Based Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Diabetes and cognitive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Establishing genomic/transcriptomic links between Alzheimer's disease and type 2 diabetes mellitus by meta-analysis approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Brain atrophy in type 2 diabetes: regional distribution and influence on cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Type 2 diabetes mellitus and biomarkers of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Resting-state brain functional connectivity is altered in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Human cerebral neuropathology of Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Insulin resistance and Alzheimer's disease: molecular links & clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

White matter hyperintensities in middle-aged adults with childhood-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Normal sequences of muscarinic acetylcholine receptors (m1 and m2) in patients with Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Vascular niche for adult hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Foetal programming and cortisol secretion in early childhood: A meta-analysis of different programming variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Protection against cerebral malaria by the low-molecular-weight thiol pantethine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

A matter of insulin: developmental programming of body weight regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Insulin-resistant brain state (IRBS) changes membrane composition of fatty acids in temporal and entorhinal brain cortices of rats: relevance to sporadic Alzheimer’s disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Orally Active Multi-Functional Antioxidants Delay Cataract Formation in Streptozotocin (Type 1) Diabetic and Gamma-Irradiated Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Invokana (Canagliflozin) as a dual inhibitor of acetylcholinesterase and sodium glucose co-transporter 2: advancement in Alzheimer's disease- diabetes type 2 linkage via an enzoinformatics study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Hippocampal alterations in rats submitted to streptozotocin-induced dementia model are prevented by aminoguanidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Impaired insulin secretion increases the risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

(Pre)diabetes, brain aging, and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Elucidation of Signaling Pathways from Large-Scale Phosphoproteomic Data Using Protein Interaction Networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Downstream modulation of extrinsic apoptotic pathway in streptozotocin-induced Alzheimer's dementia in rats: Erythropoietin versus curcumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

The Impact of Diabetes on Cerebral Structure and Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Prediction of comparative inhibition efficiency for a novel natural ligand, galangin against human brain acetylcholinesterase, butyrylcholinesterase and 5-lipoxygenase: a neuroinformatics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Effect of alpha lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

SP600125, a competitive inhibitor of JNK attenuates streptozotocin induced neurocognitive deficit and oxidative stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Effect of intranasal insulin on cognitive function: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Intracerebroventricular administration of an insulin analogue recovers STZ-induced cognitive decline in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

European Diabetes Working Party for Older People 2011 Clinical Guidelines for Type 2 Diabetes Mellitus. Executive Summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Diabetes in older people: new insights and remaining challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Effect of a diabetic environment in utero on predisposition to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Bacteriophage--a common divergent therapeutic approach for Alzheimer's disease and type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Different patterns of cerebral injury in dementia with or without diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Brain insulin resistance deteriorates cognition by altering the topological features of brain networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Long-Term Effects of Intracerebroventricular Streptozotocin Treatment on Adult Neurogenesis in the Rat Hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Insulin facilitates the hepatic clearance of plasma amyloid beta-peptide (1 40) by intracellular translocation of low-density lipoprotein receptor-related protein 1 (LRP-1) to the plasma membrane in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Mitochondrial proteome analysis reveals depression of the Ndufs3 subunit and activity of complex I in diabetic rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment - Beyond classical regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Fasting and post-glucose load measures of insulin resistance and risk of ischemic stroke in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Central angiotensin converting enzyme facilitates memory impairment in intracerebroventricular streptozotocin treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Assessing potential glycemic overtreatment in persons at hypoglycemic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Neurodegeneration in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Diffusion tensor imaging in type 1 diabetes: decreased white matter integrity relates to cognitive functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Brain imaging in patients with diabetes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Brain lesions on MRI in elderly patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Kynurenines in the CNS: recent advances and new questions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Coping style and depression influence the healing of diabetic foot ulcers: observational and mechanistic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

The role of type 2 diabetes in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Alternative fuel--another role for p53 in the regulation of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Butyrylcholinesterase K variant and Alzheimer's disease risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

IRS proteins and the common path to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Insulin resistance predicts medial temporal hypermetabolism in mild cognitive impairment conversion to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Adult neurogenesis in neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Characterization of Cerebral Damage in a Monkey Model of Alzheimer's Disease Induced by Intracerebroventricular Injection of Streptozotocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Role of insulin and insulin receptor in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

The blood-brain barrier in health and chronic neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Severe hypoglycemia and risks of vascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-017-1763-2

Dysfunctional Pro-Ceramide, ER Stress, and Insulin/IGF Signaling Networks with Progression of Alzheimer's Disease

21 January 2018

1 reference

12 December 2020

Butyrylcholinesterase in metabolic syndrome

1 reference

12 December 2020

Complexes formation between insulin receptor and extracellular signal-regulated kinases ERKs

1 reference

12 December 2020

Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1

1 reference

12 December 2020

Redox Proteomics Analysis of Brains from Subjects with Amnestic Mild Cognitive Impairment Compared to Brains from Subjects with Preclinical Alzheimer's Disease: Insights into Memory Loss in MCI

1 reference

12 December 2020

Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia

1 reference

12 December 2020

Variation in the FTO gene locus is associated with cerebrocortical insulin resistance in humans

1 reference

12 December 2020

Trimetazidine prevents oxidative changes induced in a rat model of sporadic type of Alzheimer's disease

1 reference

12 December 2020

Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease

1 reference

12 December 2020

Type 2 diabetes and cognitive impairment: linking mechanisms

1 reference

12 December 2020

Insulin and Alzheimer's Disease: Untangling the Web

1 reference

12 December 2020

Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.

1 reference

12 December 2020

Contribution of cytoskeleton to the internalization of AMPA receptors

1 reference

12 December 2020

Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity

1 reference

12 December 2020

Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment.

1 reference

12 December 2020

Diabetes mellitus and dementia

1 reference

12 December 2020

Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein.

1 reference

12 December 2020

CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer's Disease

1 reference

12 December 2020

Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors

1 reference

12 December 2020

Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus

1 reference

12 December 2020

The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared.

1 reference

12 December 2020

Amyloid-β and Tau Pathology of Alzheimer's Disease Induced by Diabetes in a Rabbit Animal Model

1 reference

12 December 2020

Cerebral Pathology and Cognition in Diabetes: The Merits of Multiparametric Neuroimaging

1 reference

12 December 2020

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes

1 reference

12 December 2020

Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia

1 reference

12 December 2020

Long-term effect of diabetes and its treatment on cognitive function.

1 reference

12 December 2020

Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors

1 reference

12 December 2020

Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.

1 reference

12 December 2020

Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease

1 reference

12 December 2020

Brain imaging changes associated with risk factors for cardiovascular and cerebrovascular disease in asymptomatic patients

1 reference

12 December 2020

Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease

1 reference

12 December 2020

Cerebrospinal fluid levels of Alzheimer’s disease biomarkers in middle-aged patients with type 1 diabetes

1 reference

12 December 2020

Insulin/IGF signaling-related gene expression in the brain of a sporadic Alzheimer's disease monkey model induced by intracerebroventricular injection of streptozotocin

1 reference

12 December 2020

Insulin resistance and Alzheimer's disease

1 reference

12 December 2020

Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics

1 reference

12 December 2020

Current medical aspects of pantethine

1 reference

12 December 2020

10.1007/S00702-017-1763-2

Identifiers

DOI

1 reference

Dimensions Publication ID

17 September 2017

1090934400

0 references

1 reference